Vimarsana
Biggest News Aggregation in the World

Page 3 - Nasdaq Huma News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Nasdaq Huma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Nasdaq Huma Today - Breaking & Trending Today

Head to Head Survey: Humacyte (NASDAQ:HUMA) and Avalon GloboCare (NASDAQ:ALBT) - Vimarsana News

Head to Head Survey: Humacyte (NASDAQ:HUMA) and Avalon GloboCare (NASDAQ:ALBT)

Humacyte (NASDAQ:HUMA – Get Free Report) and Avalon GloboCare (NASDAQ:ALBT – Get Free Report) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, risk, institutional ownership, profitability, analyst recommendations, valuation and dividends. Volatility and Risk Humacyte has a beta of […]

Benchmark Trims Humacyte (NASDAQ:HUMA) Target Price to $15.00 - Vimarsana News

Benchmark Trims Humacyte (NASDAQ:HUMA) Target Price to $15.00

Humacyte (NASDAQ:HUMA – Free Report) had its price target cut by Benchmark from $16.00 to $15.00 in a research report report published on Wednesday morning, Benzinga reports. They currently have a buy rating on the stock. A number of other brokerages also recently weighed in on HUMA. Piper Sandler lowered their price objective on shares […]

Humacyte, Inc. (NASDAQ:HUMA) Short Interest Up 10.7% in November - Vimarsana News

Humacyte, Inc. (NASDAQ:HUMA) Short Interest Up 10.7% in November

Humacyte, Inc. (NASDAQ:HUMA – Get Free Report) was the recipient of a significant growth in short interest in November. As of November 15th, there was short interest totalling 6,090,000 shares, a growth of 10.7% from the October 31st total of 5,500,000 shares. Based on an average daily trading volume, of 583,200 shares, the short-interest ratio […]

Humacyte Publishes Preclinical Results Showing Human - Vimarsana News

Humacyte Publishes Preclinical Results Showing Human

-Outcomes exhibit potential of HAV for palliative treatment of congenital heart disease-...

Humacyte, Inc. (NASDAQ:HUMA) Short Interest Up 38.2% in September - Vimarsana News

Humacyte, Inc. (NASDAQ:HUMA) Short Interest Up 38.2% in September

Humacyte, Inc. (NASDAQ:HUMA – Get Free Report) was the target of a large growth in short interest in September. As of September 15th, there was short interest totalling 5,250,000 shares, a growth of 38.2% from the August 31st total of 3,800,000 shares. Based on an average trading volume of 670,100 shares, the short-interest ratio is […]